NewEdge Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.51K | Hold |
209
| – | – | ﹤0.01% | 3435 |
|
|
2025
Q1 | $3.47K | Hold |
209
| – | – | ﹤0.01% | 3396 |
|
|
2024
Q4 | $3.84K | Hold |
209
| – | – | ﹤0.01% | 3303 |
|
|
2024
Q3 | $3.21K | Hold |
209
| – | – | ﹤0.01% | 3296 |
|
|
2024
Q2 | $3.4K | Hold |
209
| – | – | ﹤0.01% | 3205 |
|
|
2024
Q1 | $3.86K | Hold |
209
| – | – | ﹤0.01% | 3226 |
|
|
2023
Q4 | $6.54K | Buy |
209
+109
| +109% | +$3.41K | ﹤0.01% | 3024 |
|
|
2023
Q3 | $2.08K | Sell |
100
-100
| -50% | -$2.08K | ﹤0.01% | 3037 |
|
|
2023
Q2 | $4.79K | Hold |
200
| – | – | ﹤0.01% | 2834 |
|
|
2023
Q1 | $3.76K | Sell |
200
-209
| -51% | -$3.93K | ﹤0.01% | 2867 |
|
|
2022
Q4 | $3.33K | Buy |
+409
| New | +$3.33K | ﹤0.01% | 2716 |
|